Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression
Article in Immunopharmacology and Immunotoxicology (May 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
LKB1 prevents ILC2 exhaustion to enhance antitumor immunity
Article in Cell Reports (April 2024)
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development
Article in Nature Communications (October 2023)